Exane Derivatives’s Parker-Hannifin PH Stock Holding History

Exane Derivatives’s Portfolio PH Stock Details PH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-149	Closed	-$41.7K	–	939
2021 Q3	$41.7K	Buy	149 +46	+45%	+$13.7K	0.01%	636
2021 Q2	$31.9K	Buy	+103	New	+$31.9K	0.01%	681

Other funds holding PH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Exane Derivatives's PH Position: Q4 2021 in Review

Exane Derivatives sold out of Parker-Hannifin (PH) in Q4 2021, closing a stake of 149 shares — an estimated $41.7K sold.

Exane Derivatives first reported a position in PH in Q2 2021 and held it in 2 quarters. The position peaked at $41.7K in Q3 2021. 979 funds tracked by Wall St. Rank hold PH as of Q4 2021.

Exane Derivatives reported no remaining Parker-Hannifin position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 149 Parker-Hannifin shares in Q4 2021, an estimated $41.7K.
Exane Derivatives first reported a position in Parker-Hannifin in Q2 2021 and held it in 2 quarters.
Exane Derivatives's Parker-Hannifin position peaked at $41.7K in Q3 2021.
979 funds tracked by Wall St. Rank held Parker-Hannifin as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.